Genetically Proxied Interleukin‐13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study

Documenti analoghi

• Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis
  di: Melissa Tordoff, et al.
  Pubblicazione: (2024)
• Comparative Effectiveness of Abatacept Versus Adalimumab in Shared Epitope Positive and Negative Patients With Rheumatoid Arthritis
  di: Chuan Fu Yap, et al.
  Pubblicazione: (2025)
• Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole‐Blood Transcriptomics Data
  di: Chuan Fu Yap, et al.
  Pubblicazione: (2025)
• Familial Aggregation in Psoriatic Arthritis: Phenotypic Differences in Patients With and Without a Family History of Psoriatic Disease
  di: Catherine Howe, et al.
  Pubblicazione: (2025)
• Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis
  di: Stefan Siebert, et al.
  Pubblicazione: (2024)